Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership

Contributed by: Business Wire

Tags

Research
Infectious Diseases
Genetics
Clinical Trials
Health Technology
Stem Cells
Biotechnology
Health
Science
Other Science
Takara Bio USA, Inc.

More Like This

PR Newswire associated0

ToolGen Files Patent Infringement Lawsuit Against Vertex in the United Kingdom

GlobeNewswire associated0

BioProcess360 Partners Launches New Chromatography Company Through Transfer of IP, Assets and Personnel from LigaTrap Technologies

PR Newswire associated0

Chromatin Bioscience Signs Collaboration Agreement with Astellas

ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9

Business Wire logo

Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases

PR Newswire associated0

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

MiLaboratories co-founders: Dmitry Chudakov, Stan Poslavsky, Dmitry Bolotin, Alexey Nechaev (Photo: Business Wire)

MiLaboratories Secures Series A, Raising Total Funding to $10 Million to Revolutionize the World of Genomic Research

(Graphic: Business Wire)

bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology